TABLE OF CONTENTS
|  | | | Volume 51, Issue 11 (November 2016) |  | In this issue
 Editorial
Perspective
Reviews
Special Reports
Original Articles
Letters to the Editor
Also new
   AOP | | | | | | Advertisement | | | | | | | Editorial | Top | | Thirty years of Bone Marrow Transplantation R P Gale Bone Marrow Transplant 2016 51: 1411-1412; advance online publication, July 4, 2016; 10.1038/bmt.2016.175 Full Text | | Perspective | Top | | Is there really a specific graft-versus-leukaemia effect? R P Gale and E J Fuchs Bone Marrow Transplant 2016 51: 1413-1415; advance online publication, July 11, 2016; 10.1038/bmt.2016.183 Full Text | | Reviews | Top | | A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions A J Applebaum, M Bevans, T Son, K Evans, M Hernandez, S Giralt and K DuHamel Bone Marrow Transplant 2016 51: 1416-1422; advance online publication, June 13, 2016; 10.1038/bmt.2016.164 Abstract | Full Text | | Life after transplant: are we becoming high maintenance in AML? A M Brunner, A T Fathi and Y B Chen Bone Marrow Transplant 2016 51: 1423-1430; advance online publication, June 20, 2016; 10.1038/bmt.2016.160 Abstract | Full Text | | Special Reports | Top | | Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT P Tsirigotis, M Byrne, C Schmid, F Baron, F Ciceri, J Esteve, N C Gorin, S Giebel, M Mohty, B N Savani and A Nagler Bone Marrow Transplant 2016 51: 1431-1438; advance online publication, June 13, 2016; 10.1038/bmt.2016.167 Abstract | Full Text | | What is the P-value anyway? R P Gale and M-J Zhang Bone Marrow Transplant 2016 51: 1439-1440; advance online publication, July 11, 2016; 10.1038/bmt.2016.184 Full Text | | Original Articles | Top | | ACUTE LEUKEMIA | Outcome of allogeneic stem cell transplantation for AML and myelodysplastic syndrome in elderly patients (⩾ 60 years) M Pohlen, C Groth, T Sauer, D Görlich, R Mesters, C Schliemann, G Lenz, C Müller-Tidow, T Büchner, W E Berdel and M Stelljes Bone Marrow Transplant 2016 51: 1441-1448; advance online publication, June 13, 2016; 10.1038/bmt.2016.156 Abstract | Full Text | | PLASMA CELL DISORDERS | Autologous stem cell transplant for multiple myeloma patients 70 years or older E Muchtar, D Dingli, S Kumar, F K Buadi, A Dispenzieri, S R Hayman, R C Wolf, D A Gastineau, R Chakraborty, W J Hogan, N Leung, P Kapoor, M Q Lacy, S V Rajkumar and M A Gertz Bone Marrow Transplant 2016 51: 1449-1455; advance online publication, July 4, 2016; 10.1038/bmt.2016.174 Abstract | Full Text | | APLASTIC ANEMIA | Comparable outcomes between younger (⩽ 40 years) and older (>40 years) adult patients with severe aplastic anemia after HLA-matched sibling stem cell transplantation using fludarabine-based conditioning S H Shin, Y W Jeon, J H Yoon, S A Yahng, S E Lee, B S Cho, K S Eom, Y J Kim, S Lee, C K Min, H J Kim, S G Cho, D W Kim, W S Min and J W Lee Bone Marrow Transplant 2016 51: 1456-1463; advance online publication, June 27, 2016; 10.1038/bmt.2016.171 Abstract | Full Text | | GRAFT SOURCE | Haploidentical, unmanipulated G-CSF-primed peripheral blood stem cell transplantation for high-risk hematologic malignancies: an update W-R Huang, H-H Li, C-J Gao, J Bo, F Li, L-P Dou, L-L Wang, Y Jing, L Wang, D-H Liu and L Yu Bone Marrow Transplant 2016 51: 1464-1469; advance online publication, June 20, 2016; 10.1038/bmt.2016.166 Abstract | Full Text | | Long-term outcomes of HLA-haploidentical stem cell transplantation based on an FBCA conditioning regimen compared with those of HLA-identical sibling stem cell transplantation for haematologic malignancies H Long, Z G Lu, C Y Song, Y X Huang, J H Xu, J X Xu, L Deng, S F Tu, Y Z He, X Lin, K Y Guo and B Y Wu Bone Marrow Transplant 2016 51: 1470-1475; advance online publication, June 20, 2016; 10.1038/bmt.2016.170 Abstract | Full Text | | HISTOCOMPATIBILITY AND DONOR SELECTION ISSUES | Unrelated donor search prognostic score to support early HLA consultation and clinical decisions K Wadsworth, M Albrecht, R Fonstad, S Spellman, M Maiers and J Dehn Bone Marrow Transplant 2016 51: 1476-1481; advance online publication, June 6, 2016; 10.1038/bmt.2016.162 Abstract | Full Text | | TRANSPLANT TOXICITIES | Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters D Bresters, A Lawitschka, C Cugno, U Pötschger, A Dalissier, G Michel, K Vettenranta, M Sundin, A Al-Seraihy, M Faraci, P Sedlacek, A B Versluys, A Jenkins, P Lutz, B Gibson, A Leiper, M A Diaz, P J Shaw, R Skinner, T A O'Brien, N Salooja, P Bader and C Peters Bone Marrow Transplant 2016 51: 1482-1489; advance online publication, June 27, 2016; 10.1038/bmt.2016.139 Abstract | Full Text | | INFECTIONS | Bacterial meningitis in hematopoietic stem cell transplant recipients: a population-based prospective study K E B van Veen, M C Brouwer, A van der Ende and D van de Beek Bone Marrow Transplant 2016 51: 1490-1495; advance online publication, July 4, 2016; 10.1038/bmt.2016.181 Abstract | Full Text | | Letters to the Editor | Top | | The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center S K Bae, T Gushima, N Saito, I Yamanaka, T Shimokawa, Y Matsuo, S Yoshida, I Kawano, H Henzan, S Shimoda, T Eto and K Takahashi Bone Marrow Transplant 2016 51: 1496-1498; advance online publication, June 6, 2016; 10.1038/bmt.2016.149 Full Text | | Impact of KIR/HLA genetic combinations on double umbilical cord blood transplantation outcomes. Results of a French multicentric retrospective study on behalf of the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Société Francophone d’Histocompatibilité et d’Immunogénétique (SFHI) P Rettman, F Malard, N Legrand, O Avinens, J-F Eliaou, C Picard, A Dormoy, X Lafarge, M de Matteis, A Kennel, P Loiseau, A Devys, A Boudifa, L Absi, M Fort, D Masson, F Quainon, I Theodorou, A Batho, A Parissiadis, F Delbos, M Drouet, D Senitzer, E Marry, N Raus, I Yakoub-Agha, A Cesbron, C Retière and K Gagne Bone Marrow Transplant 2016 51: 1499-1503; advance online publication, June 6, 2016; 10.1038/bmt.2016.151 Full Text | | Management of refractory autoimmune hemolytic anemia via allogeneic stem cell transplantation L Rotenstein, A Nathan, I Ghobrial, J Antin and A Parnes Bone Marrow Transplant 2016 51: 1504-1506; advance online publication, June 6, 2016; 10.1038/bmt.2016.152 Full Text | | Focused extracorporeal shock wave for osteonecrosis of the femoral head with leukemia after allo-HSCT: a case series W Sun, F Gao, W Guo, B Wang, Z Li, L Cheng and W Wang Bone Marrow Transplant 2016 51: 1507-1509; advance online publication, June 6, 2016; 10.1038/bmt.2016.155 Full Text | | Risk of serious bloodstream infections is low in pediatric hematopoietic stem cell transplant (HSCT) recipients with fevers due to antithymocyte globulins and alemtuzumab B Horn, S O'Kane, R L Wattier, J T Wahlstrom, A Melton, M J Cowan and C C Dvorak Bone Marrow Transplant 2016 51: 1510-1512; advance online publication, June 6, 2016; 10.1038/bmt.2016.157 Full Text | | High prevalence of small- and large-fiber neuropathy in a prospective cohort of patients with moderate to severe chronic GvHD E Bilic, V Delimar, L Desnica, D Pulanic, E Bilic, M Bakovic, L M Curtis, R S Seiwerth, M M Stipetic, R Ceovic, T K Pulanic, I Aleric, O Milos, R Vrhovac, D Nemet and S Z Pavletic Bone Marrow Transplant 2016 51: 1513-1517; advance online publication, June 6, 2016; 10.1038/bmt.2016.158 Full Text | | High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis M Remberger, G Afram, M Sundin, M Uhlin, K LeBlanc, A Björklund, J Mattsson and P Ljungman Bone Marrow Transplant 2016 51: 1518-1521; advance online publication, June 6, 2016; 10.1038/bmt.2016.159 Full Text | | Successful matched unrelated donor stem cell transplant in Hemoglobin Bart's disease M Y Elsaid, C M Capitini, C A Diamond, M Porte, M Otto and K B DeSantes Bone Marrow Transplant 2016 51: 1522-1523; advance online publication, June 13, 2016; 10.1038/bmt.2016.153 Full Text | | GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study R Parody, L López-Corral, O Lopez-Godino, C Martinez, R Martino, C Solano, P Barba, D Caballero, I García-Cadenas, J L Piñana, F J Marquez-Malaver, L Vazquez, A Esquirol, J C H Boluda, F Sanchez-Guijo and J A Pérez-Simon on behalf of the GETH (Grupo Español de TrasplanteHematopoyético) Bone Marrow Transplant 2016 51: 1524-1526; advance online publication, June 13, 2016; 10.1038/bmt.2016.163 Full Text | | Long-term follow-up of patients with relapsed or refractory non-Hodgkin’s lymphoma receiving allogeneic stem cell transplantation C S Link, F Mies, J Scheele, M Kramer, J Schetelig, R Ordemann, M Hänel, M Bornhäuser, G Ehninger and F Kroschinsky Bone Marrow Transplant 2016 51: 1527-1529; advance online publication, June 13, 2016; 10.1038/bmt.2016.165 Full Text | | Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning R Majzner, C Sandoval, A J Dozor, Z Jin, C van de Ven, R Dalal, E Morris, L Harrison, K Wolownik, S Fabricatore, L A Baxter-Lowe and M S Cairo Bone Marrow Transplant 2016 51: 1530-1532; advance online publication, June 20, 2016; 10.1038/bmt.2016.172 Full Text | | Unusual magnetic resonance imaging presentation of post-BMT cerebral toxoplasmosis masquerading as meningoencephalitis and ventriculitis K J Helton, G Maron, E Mamcarz, V Leventaki, Z Patay and Z Sadighi Bone Marrow Transplant 2016 51: 1533-1536; advance online publication, June 27, 2016; 10.1038/bmt.2016.168 Full Text | | Differences in stem cell transplantation activity among regions in Spain: an economic explanation I Espigado, M Ortega-Ortega, R Montero-Granados, N Rodriguez-Torres and F J Márquez-Malaver Bone Marrow Transplant 2016 51: 1537-1539; advance online publication, July 4, 2016; 10.1038/bmt.2016.177 Full Text | | Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy H Sakaguchi, K Matsumoto, N Yoshida, K Narita, M Hamada, S Kataoka, N Miyagawa, T Yoshikawa, M Ito and K Kato Bone Marrow Transplant 2016 51: 1540-1542; advance online publication, July 4, 2016; 10.1038/bmt.2016.178 Full Text | | Heterogeneous response to recombinant thrombomodulin by grade of sinusoidal obstructive syndrome after pediatric stem cell transplantation J Inagaki, K Kurauchi, R Fukano, M Noguchi and J Okamura Bone Marrow Transplant 2016 51: 1543-1545; advance online publication, July 4, 2016; 10.1038/bmt.2016.179 Full Text | | Haploidentical transplantation with post-transplant cyclophosphamide following reduced-intensity conditioning for osteopetrosis: outcomes in three children T L Bahr, T Lund, N M Sando, P J Orchard and W P Miller Bone Marrow Transplant 2016 51: 1546-1548; advance online publication, July 4, 2016; 10.1038/bmt.2016.180 Full Text | | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | | | |
No comments:
Post a Comment